Dare Bioscience, Inc.DARE
What Dare Bioscience, Inc. does.
The terms “we,” “us,” “our,” “Daré” or the “Company” refer collectively to Daré Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years.
We are a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions. Every innovation we advance is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, pelvic pain to fertility, vaginal health to infectious disease, we’re working to close critical gaps in care using science that serves her needs.
For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $10.0M | $2.8M | $9,784 | $1.0M |
| Net income | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| Free cash flow | -$25.3M | -$28.8M | -$18.2M | -$39.5M | $4.9M | -$10.3M |
More on DARE.
- Dare Bioscience, Inc. summary
- Dare Bioscience, Inc. financial statements
- Dare Bioscience, Inc. key metrics
- Dare Bioscience, Inc. health scores and style box
- Dare Bioscience, Inc. earnings
- Dare Bioscience, Inc. dividends
- Dare Bioscience, Inc. valuation
- Dare Bioscience, Inc. ownership and insiders
- Dare Bioscience, Inc. peers
Figures from Dare Bioscience, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.